« Return to News | Awards & Advancement

McGoldrick Leaves DIA, Brassington Named Acting Executive Director

Wednesday, August 6, 2008 08:01 AM

Linda McGoldrick, appointed executive director of the Drug Information Association (DIA) earlier this year, has left her position, according to a release on the DIA’s web site.

In her place, the DIA appointed William Brassington as acting executive director on an interim basis. The statement didn’t disclose why McGoldrick left.

According to the statement from Marie Dray, president DIA’s Board of Directors, Brassington has a long history of service with DIA. Since August 2003, he has been chief financial officer, and he served as acting executive director before McGoldrick was hired.

“Through these roles, William has gained the respect and confidence of the DIA staff, the Board of Directors and association members, enabling him to ensure seamless operations during this transition period,” Dray said in the statement.

The 18,000-member association provides a global exchange of drug information, and conducts education and training programs. In June, DIA hosted its most successful annual meeting in Boston with almost 9,000 members and speakers in attendance. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.